Related references
Note: Only part of the references are listed.Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction
Qiaozhen Liu et al.
NATURE GENETICS (2019)
Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors
Jay Gong et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
Jie Zhang et al.
CANCER COMMUNICATIONS (2019)
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
Trine Vilsboll Larsen et al.
CANCER COMMUNICATIONS (2019)
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Lanqi Gong et al.
CANCER COMMUNICATIONS (2019)
Histologic transformation of non-small-cell lung cancer in brain metastases
Meng Jiang et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor
Sehhoon Park et al.
LUNG CANCER (2019)
Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
Fang Wang et al.
CANCER COMMUNICATIONS (2019)
Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
Yangyang Liu
CANCER BIOLOGY & THERAPY (2018)
Squamous Cell Carcinoma Transformation from EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review
Hiroki Izumi et al.
CLINICAL LUNG CANCER (2018)
Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series
Tahreem Ahmed et al.
LUNG CANCER (2018)
Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: A case report
Yufeng Yao et al.
MEDICINE (2018)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Mariano J. Alvarez et al.
NATURE GENETICS (2018)
Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer
Shinji Shinohara et al.
JOURNAL OF THORACIC DISEASE (2018)
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Ugo Testa et al.
CANCERS (2018)
An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib
Mitsuo Sato et al.
INTERNAL MEDICINE (2018)
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
Jung Wook Park et al.
SCIENCE (2018)
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
Tim D. D. Somerville et al.
CELL REPORTS (2018)
FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer
Soledad A. Camolotto et al.
ELIFE (2018)
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study
Shirong Zhang et al.
CANCER COMMUNICATIONS (2018)
Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature
Monalisa Hui et al.
LUNG INDIA (2018)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report
Rika Moriya et al.
INTERNAL MEDICINE (2017)
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression
Eduardo Clery et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
Chia-Lin Hsu et al.
Journal of Thoracic Oncology (2017)
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation
Eric Santoni-Rugiu et al.
LUNG CANCER (2017)
Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer
Nadza Tokaca et al.
LUNG CANCER (2017)
Synchronous occurrence of squamous-cell carcinoma transformation and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma
Lucia Longo et al.
LUNG CANCER (2017)
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition
Tri Le et al.
LUNG CANCER (2017)
Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells
Kenichi Suda et al.
LUNG CANCER (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Haikuo Zhang et al.
NATURE COMMUNICATIONS (2017)
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou et al.
CANCER DISCOVERY (2017)
Sequential occurrence of small cell and non-small lung cancer in a male patient: Is it a transformation?
Ahsan Wahab et al.
CANCER BIOLOGY & THERAPY (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation
Hsinyi Huang et al.
CANCER RESEARCH (2017)
A case of resistance to tyrosine kinase inhibitor therapy: small cell carcinoma transformation concomitant with plasma-genotyped T790M positivity
Yanjun Xu et al.
ANTI-CANCER DRUGS (2017)
Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
Hyung Kyu Park et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Lysyl Oxidase and the Tumor Microenvironment
Tong-Hong Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E. Gardner et al.
CANCER CELL (2017)
Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib
K. Haratani et al.
ANNALS OF ONCOLOGY (2016)
Molecular mechanisms of drug resistance and its reversal in cancer
Melis Kartal-Yandim et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors
Quan Lin et al.
BMC CANCER (2016)
Squamous Cell Carcinoma Transformation Concurrent with Secondary T790M Mutation in Resistant EGFR-Mutated Adenocarcinomas
Agita Jukna et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib
Yoon Jin Cha et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib
Shiro Fujita et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature
Bradford J. Siegele et al.
LUNG CANCER (2016)
Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
Shi-Yu Jiang et al.
MEDICINE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma
Greta Ali et al.
ONCOLOGY LETTERS (2016)
Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment
Min-Shu Hsieh et al.
ANNALS OF THORACIC SURGERY (2015)
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
Fuming Li et al.
CANCER CELL (2015)
YAP Promotes Malignant Progression of Lkb1-Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
Wenjing Zhang et al.
CANCER RESEARCH (2015)
Exuberant squamous metaplasia of the gastric mucosa in a patient with gastric adenocarcinoma
Sangjeong Ahn et al.
DIAGNOSTIC PATHOLOGY (2015)
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor
Justine L. Kuiper et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition
Pavel A. Levin et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor
Mariko Kogo et al.
LUNG CANCER (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations
Zhijie Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin
Ki-Eun Hwang et al.
TUMORI JOURNAL (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
Kenichi Suda et al.
SCIENTIFIC REPORTS (2015)
Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin
Ki-Eun Hwang et al.
TUMORI JOURNAL (2015)
Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
Woo-Jin Kim et al.
THORACIC CANCER (2015)
Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
Brenda K. Edwards et al.
CANCER (2014)
Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation-a report of two cases
Torin Glass et al.
CHILDS NERVOUS SYSTEM (2014)
Primary Adenosquamous Carcinoma of the Prostate: A Rare Aggressive Tumor
Shwetank Mishra et al.
CLINICAL GENITOURINARY CANCER (2014)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
Xiangkun Han et al.
NATURE COMMUNICATIONS (2014)
YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression
Yijun Gao et al.
NATURE COMMUNICATIONS (2014)
Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer
Anandaroop Mukhopadhyay et al.
CELL REPORTS (2014)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
Growing teratoma syndrome: An unrecognized complication of treated germ cell tumors of the testis
Merieme Ghaouti et al.
ANNALES DE PATHOLOGIE (2013)
EGFR-Mutated Lung Cancer With T790M-Acquired Resistance in the Brain and Histologic Transformation in the Lung
Kevin S. Scher et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Transformation to high grade neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma
S. Popat et al.
LUNG CANCER (2013)
Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
Yan Zhang et al.
LUNG CANCER (2013)
Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma
Satoshi Watanabe et al.
LUNG CANCER (2013)
Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer
Pengbo Deng et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung
Ada T. W. Ma et al.
ACTA ONCOLOGICA (2012)
A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation
S. van Riel et al.
ANNALS OF ONCOLOGY (2012)
Histological variants of prostatic carcinoma and their significance
Peter A. Humphrey
HISTOPATHOLOGY (2012)
The growing teratoma syndrome in primary mediastinal nonseminomatous germ cell tumors: Criteria based on current practice
Kenneth A. Kesler et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Adenosquamous Carcinoma of the Lung A Microdissection Study of KRAS and EGFR Mutational and Amplification Status in a Western Patient Population
Naohumi Tochigi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Christina Scheel et al.
CELL (2011)
Papillary carcinoma with extensive squamous metaplasia arising from thyroglossal duct cyst in an 11-year-old girl: significance of differentiation from squamous cell carcinoma: a case report
Kiyoshi Gomi et al.
JOURNAL OF PEDIATRIC SURGERY (2011)
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
Natasha Rekhtman et al.
MODERN PATHOLOGY (2011)
Clinicopathological features of adenosquamous pancreatic cancer
Paolo Regi et al.
LANGENBECKS ARCHIVES OF SURGERY (2011)
EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung
Xiao-Li Jia et al.
LUNG CANCER (2011)
Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations
Keita Kudo et al.
LUNG CANCER (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Primary adenosquamous carcinoma of the colon
Dong Baek Kang et al.
JOURNAL OF THE KOREAN SURGICAL SOCIETY (2011)
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
Yang Wang et al.
CANCER SCIENCE (2010)
Small-Cell Carcinoma With an Epidermal Growth Factor Receptor Mutation in a Never-Smoker With Gefitinib-Responsive Adenocarcinoma of the Lung
Naheed Alam et al.
CLINICAL LUNG CANCER (2010)
Thyroid carcinoma with papillary and squamous features: Report of a case with histogenetic considerations
Th. Rausch et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling
Yijun Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Combined Small Cell Lung Carcinomas Genotypic and Immunophenotypic Analysis of the Separate Morphologic Components
Patrick L. Wagner et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
Ryotaro Morinaga et al.
LUNG CANCER (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung
Shin Myung Kang et al.
CANCER (2007)
EGFR mutations in small-cell lung cancers in patients who have never smoked
MF Zakowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
EGFR mutation in gefitinib-responsive small-cell lung cancer
I Okamoto et al.
ANNALS OF ONCOLOGY (2006)
Prostatic adenosquamous carcinoma metastasizing to testis
Dilek Ertoy Baydar et al.
THESCIENTIFICWORLDJOURNAL (2006)
Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung
F Barlési et al.
BRITISH JOURNAL OF CANCER (2005)
Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer
J Araki et al.
LUNG CANCER (2005)
Adenosquamous carcinoma of the prostate
T Egilmez et al.
INTERNATIONAL JOURNAL OF UROLOGY (2005)
Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance
E Ruffini et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2002)
Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy
K Miura et al.
PATHOLOGY INTERNATIONAL (2001)
Share Paper
